Lee Ainslie – ALNY history

Issuer:
ALNYLAM PHARMACEUTICALS INC
Quarters tracked:
16 (Q2 2018 → Q3 2026)
Current shares:
907
Current value:
$224K
Peak shares:
4,236,016 (Q2 2019)
Overall change:
-100%
QuarterSharesValue$/ShareShare ΔΔ%
Q3 2026907$224K$246.97+907+100%
Q4 2021SOLD——-3,983-100%
Q3 20213,983$752K$188.80-288,700-99%
Q2 2021292,683$49.62M$169.52-503,551-63%
Q1 2021796,234$112.42M$141.19-188,268-19%
Q4 2020984,502$127.96M$129.97+17,041+2%
Q3 2020967,461$140.86M$145.60-146,147-13%
Q2 20201,113,608$164.94M$148.11-226,097-17%
Q1 20201,339,705$145.83M$108.85-921,192-41%
Q4 20192,260,897$260.39M$115.17-961,916-30%
Q3 20193,222,813$259.18M$80.42-1,013,203-24%
Q2 20194,236,016$307.37M$72.56+1,025,629+32%
Q1 20193,210,387$300.01M$93.45+406,436+14%
Q4 20182,803,951$204.44M$72.91+1,291,887+85%
Q3 20181,512,064$132.34M$87.52+830,710+122%
Q2 2018681,354$67.11M$98.49—NEW